Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation

被引:142
作者
Im, Jin S. [1 ]
Arora, Pooja [1 ]
Bricard, Gabriel [1 ]
Molano, Alberto [1 ]
Venkataswamy, Manjunatha M. [1 ]
Baine, Ian [1 ]
Jerud, Elliot S. [1 ]
Goldberg, Michael F. [1 ]
Baena, Andres [1 ]
Yu, Karl O. A. [1 ]
Ndonye, Rachel M. [3 ]
Howell, Amy R. [3 ]
Yuan, Weiming [4 ,5 ]
Cresswell, Peter [4 ,5 ]
Chang, Young-tae [6 ,7 ]
Illarionov, Petr A. [8 ]
Besra, Gurdyal S. [8 ]
Porcelli, Steven A. [1 ,2 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[3] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA
[4] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[6] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
[7] Natl Univ Singapore, Inst Life Sci, NUS MedChem Program, Singapore 117543, Singapore
[8] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
HUMAN CD1D MOLECULES; LIGAND ALPHA-GALACTOSYLCERAMIDE; II-PEPTIDE COMPLEXES; NKT CELLS; PLASMA-MEMBRANE; DENDRITIC CELLS; LIPID RAFTS; IN-VIVO; RECOGNITION; PROTEINS;
D O I
10.1016/j.immuni.2009.03.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CID1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating a galactosylceramide (alpha GalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for alpha GalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing alpha GalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.
引用
收藏
页码:888 / 898
页数:11
相关论文
共 45 条
[1]  
Behar SM, 2007, CURR TOP MICROBIOL, V314, P215
[2]   The biology of NKT cells [J].
Bendelac, Albert ;
Savage, Paul B. ;
Teyton, Luc .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :297-336
[3]   Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo [J].
Bezbradica, JS ;
Stanic, AK ;
Matsuki, N ;
Bour-Jordan, H ;
Bluestone, JA ;
Thomas, JW ;
Unutmaz, D ;
Van Kaer, L ;
Joyce, S .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4696-4705
[4]   CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor [J].
Borg, Natalie A. ;
Wun, Kwok S. ;
Kjer-Nielsen, Lars ;
Wilce, Matthew C. J. ;
Pellicci, Daniel G. ;
Koh, Ruide ;
Besra, Gurdyal S. ;
Bharadwaj, Mandvi ;
Godfrey, Dale I. ;
McCluskey, James ;
Rossjohn, Jamie .
NATURE, 2007, 448 (7149) :44-49
[5]   MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype [J].
Buatois, V ;
Baillet, M ;
Bécart, S ;
Mooney, N ;
Leserman, L ;
Machy, P .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5812-5819
[6]   Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids [J].
Chang, Ya-Jen ;
Huang, Jing-Rong ;
Tsai, Yi-Chien ;
Hung, Jung-Tung ;
Wu, Douglass ;
Fujio, Masakazu ;
Wong, Chi-Huey ;
Yu, Alice L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (25) :10299-10304
[7]   Differential antitumor immunity mediated by NKT cell subsets in vivo [J].
Crowe, NY ;
Coquet, JM ;
Berzins, SP ;
Kyparissoudis, K ;
Keating, R ;
Pellicci, DG ;
Hayakawa, Y ;
Godfrey, DI ;
Smyth, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (09) :1279-1288
[8]   Phage display-derived recombinant antibodies with TCR-like specificity against α-galactosylceramide and its analogues in complex with human CD1d molecules [J].
Denkberg, Galit ;
Stronge, Victoria S. ;
Zahavi, Efrat ;
Pittoni, Paola ;
Oren, Ravit ;
Shepherd, Dawn ;
Salio, Mariolina ;
McCarthy, Corinna ;
Illarionov, Petr A. ;
van der Merwe, Anton ;
Besra, Gurdyal S. ;
Dellabona, Paolo ;
Casorati, Giulia ;
Cerundolo, Vincenzo ;
Reiter, Yoram .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (03) :829-840
[9]   Requirements for CD1d recognition by human invariant V alpha 24(+) CD4(-)CD8(-) T cells [J].
Exley, M ;
Garcia, J ;
Balk, SP ;
Porcelli, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :109-120
[10]   Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator [J].
Forestier, Claire ;
Takaki, Toshiyuki ;
Molano, Alberto ;
Im, Jin S. ;
Baine, Ian ;
Jerud, Elliot S. ;
Illarionov, Petr ;
Ndonye, Rachel ;
Howell, Amy R. ;
Santamaria, Pere ;
Besra, Gurdyal S. ;
DiLorenzo, Teresa P. ;
Porcelli, Steven A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1415-1425